Pauls Matthew bought PTHS
July 2, 2025 · Form 4 insider transaction
Pauls Matthew bought 25,478 shares of Pelthos Therapeutics Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,478
Price
N/A
Total value
N/A
InsiderPauls Matthew
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJuly 2, 2025
Filing dateJuly 7, 2025
Shares owned after25,478
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 25,478 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years.